Guy Cipriani

Mr. Cipriani joined Oncothyreon in July 2012 as Vice President, Business Development.  A proven executive talent with an impressive track record of value creation, Mr. Cipriani has over a decade of pharmaceutical and biotech industry experience.   His extensive background includes corporate and business development, corporate strategy, alliance management, and product development.   Mr. Cipriani has successfully completed over twenty significant transactions across multiple therapeutic areas and contributed in excess of $2 billion dollars in expected economic value.

Mr. Cipriani has worked for Eli Lilly, Transform Pharma (acquired by JNJ), Cardiome Pharma, and Immune Design.  Prior to his Pharma experience, Guy was a consultant with Accenture (formerly Andersen Consulting).  

Guy holds an MBA from the Kellogg Graduate School of Management at Northwestern University and a B.S.E.E., High Honors, from Rochester Institute of Technology.